Virtify

About Virtify

Virtify, Inc. operated as a specialized provider of enterprise content and compliance software tailored for the life sciences sector. The company was founded in 2004 by Satish Tadikonda and Anmol Wassan, establishing its base in the Cambridge, Massachusetts area. Dr. Tadikonda, who served as President and CEO, brought over two decades of experience in the life sciences industry, having previously founded other ventures in scientific consulting and clinical trial management systems. The firm focused on serving pharmaceutical and biotechnology companies, offering solutions to manage the complex web of regulated content required throughout a product's lifecycle, from pre-clinical development to commercialization.

The company's business model centered on providing a suite of web-based software products, which were available for license individually or as an integrated solution. These tools were designed to replace paper-based processes, enhance collaboration, and ensure compliance with various global regulatory standards. A core offering was the Virtify Structured Content Management (SCM) platform, which enabled clients to create, manage, and reuse clinical and regulatory content in a secure, centralized library. This system aimed to improve efficiency and data accuracy for critical documentation like clinical trial disclosures, regulatory submissions, and product labeling. The product portfolio also included specific tools for Regulatory Information Management (RIM), electronic Common Technical Document (eCTD) submissions, and Structured Product Labeling (SPL).

Throughout its operation, Virtify secured approximately $23.5 million in funding over several rounds from investors including Tudor Ventures, Spring Lake Equity Partners, and Blue Cloud Ventures. The company's journey, however, concluded when it ceased operations around January 2016.